|
|
|
|
LEADER |
03595nam a22003375i 4500 |
001 |
000287854 |
005 |
20201013103308.0 |
007 |
cr nn 008mamaa |
008 |
190516s2019 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781493992201
|
024 |
7 |
|
|a 10.1007/978-1-4939-9220-1
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a RNA Interference and Cancer Therapy :
|b Methods and Protocols /
|c edited by Lekha Dinesh Kumar.
|
250 |
|
|
|a 1st ed. 2019.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2019.
|
300 |
|
|
|a XIII, 416 p. 112 illus., 84 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in Molecular Biology,
|v 1974
|
505 |
0 |
|
|a siRNA Library Screening to Identify Complementary Therapeutic Pairs in Triple Negative Breast Cancer Cells -- In Vitro Evaluation of Candidate Gene Targets for Cancer Therapy -- siRNA-Based Drug Targeting Human Bcl-xL against Cancers -- Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly-Active siRNAs -- VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier -- Design Strategy to Access siRNA-Encapsulating DNA “Nanosuitcases” that Can Conditionally Release their Cargo -- Combinatorial siRNA Polyplexes for Receptor Targeting -- Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy -- Minicell-Based Targeted Delivery of shRNA to Cancer Cells: An Experimental Protocol -- Targeted Delivery of miRNA Antagonists to Myeloid Cells In Vitro and In Vivo -- Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid Nanoparticles -- Targeting Cancer with Peptide RNAi Nanoplexes -- Preparation of a Carrier to Achieve In Vivo Delivery of siRNA: The Example of Chitosan-Coated Poly(isobutylcyanoacrylate) Nanoparticles -- Monoclonal Antibody-Conjugated Dendritic Nanostructures for siRNA Delivery -- Synthesis of Gold Nanoparticles for Gene Silencing -- Design of Eco-Friendly Gold Nanoparticles for Cancer Treatment -- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery -- Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer -- Bio-Drug Suppresses Breast and Colorectal Cancer in Murine Models -- Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment -- Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells -- Vaginal Suppositories with siRNA and Paclitaxel-Incorporated Solid Lipid Nanoparticles for Cervical Cancer: Preparation and In Vitro Evaluation -- The Use of Star Polymer Nanoparticles for the Delivery of siRNA to Mouse Orthotopic Pancreatic Tumor Models -- Microfluidic Assembly of siRNA-Loaded Micelleplexes for Tumor Targeting in an Orthotopic Model of Ovarian Cancer -- Synthesis, Physico-Chemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma -- Folate-Decorated Polyamidoamine Dendrimer Nanoparticles for Head and Neck Cancer Gene Therapy.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Human genetics.
|
650 |
|
0 |
|a Pharmaceutical technology.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Human Genetics.
|
650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
700 |
1 |
|
|a Dinesh Kumar, Lekha.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|